Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026)

Elanco Animal Health (ELAN) reported Other Non-Current Liabilities of $467.0 million for Q1 2026, down 4.11% on a YoY basis from $487.0 million in Q1 2025, and up 53.62% sequentially from $304.0 million in Q4 2025.

Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Other Non-Current Liabilities data on file, last reported at $467.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities fell 4.11% year-over-year to $467.0 million; the trailing twelve-month figure through Mar 2026 stood at $467.0 million (down 4.11% YoY), and the FY2025 full-year result was $304.0 million, up 0.66% from the prior year.
  • Other Non-Current Liabilities advanced to $467.0 million in Q1 2026, from $304.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $638.0 million in Q2 2025 to a low of $225.0 million in Q3 2022.
  • A 5-year average of $398.1 million and a median of $411.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Peak annual rise in Other Non-Current Liabilities reached 93.47% in 2024, while the deepest fall reached 26.52% in 2024.
  • Tracing ELAN's Other Non-Current Liabilities over 5 years: stood at $229.0 million in 2022, then surged by 79.48% to $411.0 million in 2023, then decreased by 26.52% to $302.0 million in 2024, then climbed by 0.66% to $304.0 million in 2025, then soared by 53.62% to $467.0 million in 2026.
  • Business Quant data shows ELAN's Other Non-Current Liabilities at $467.0 million in Q1 2026, $304.0 million in Q4 2025, and $607.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 467.00 Mn
Dec 31, 2025 304.00 Mn
Sep 30, 2025 607.00 Mn
Jun 30, 2025 638.00 Mn
Mar 31, 2025 487.00 Mn
Dec 31, 2024 302.00 Mn
Sep 30, 2024 587.00 Mn
Jun 30, 2024 465.00 Mn
Mar 31, 2024 474.00 Mn
Dec 31, 2023 411.00 Mn
Sep 30, 2023 432.00 Mn
Jun 30, 2023 411.00 Mn
Mar 31, 2023 245.00 Mn
Dec 31, 2022 229.00 Mn
Sep 30, 2022 225.00 Mn
Jun 30, 2022 242.00 Mn
Mar 31, 2022 242.00 Mn
Dec 31, 2021 262.00 Mn
Sep 30, 2021 220.00 Mn
Jun 30, 2021 237.00 Mn